These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20559098)

  • 1. Intraventricular tissue plasminogen activator for the prevention of vasospasm and hydrocephalus after aneurysmal subarachnoid hemorrhage.
    Ramakrishna R; Sekhar LN; Ramanathan D; Temkin N; Hallam D; Ghodke BV; Kim LJ
    Neurosurgery; 2010 Jul; 67(1):110-7; discussion 117. PubMed ID: 20559098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of microsurgical fenestration of the lamina terminalis on shunt-dependent hydrocephalus and vasospasm after aneurysmal subarachnoid hemorrhage.
    Komotar RJ; Hahn DK; Kim GH; Khandji J; Mocco J; Mayer SA; Connolly ES
    Neurosurgery; 2008 Jan; 62(1):123-32; discussion 132-4. PubMed ID: 18300899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of shunt-dependent chronic hydrocephalus after aneurysmal subarachnoid haemorrhage.
    Yang TC; Chang CH; Liu YT; Chen YL; Tu PH; Chen HC
    Eur Neurol; 2013; 69(5):296-303. PubMed ID: 23445755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage.
    Klimo P; Kestle JR; MacDonald JD; Schmidt RH
    J Neurosurg; 2004 Feb; 100(2):215-24. PubMed ID: 15086227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm.
    Hänggi D; Eicker S; Beseoglu K; Behr J; Turowski B; Steiger HJ
    Cent Eur Neurosurg; 2009 May; 70(2):61-7. PubMed ID: 19711257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of low-dose tissue-plasminogen activator intracisternal administration for the prevention of cerebral vasospasm after subarachnoid hemorrhage.
    Yamamoto T; Esaki T; Nakao Y; Mori K
    World Neurosurg; 2010 Jun; 73(6):675-82. PubMed ID: 20934155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Removal of clots in subarachnoid space could reduce the vasospasm after subarachnoid hemorrhage.
    de Aguiar PH; Barros I; Paiva BL; Simm RF
    Acta Neurochir Suppl; 2013; 115():91-3. PubMed ID: 22890652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraventricular hemorrhage after aneurysmal subarachnoid hemorrhage: pilot study of treatment with intraventricular tissue plasminogen activator.
    Varelas PN; Rickert KL; Cusick J; Hacein-Bey L; Sinson G; Torbey M; Spanaki M; Gennarelli TA
    Neurosurgery; 2005 Feb; 56(2):205-13; discussion 205-13. PubMed ID: 15670368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo.
    Wurm G; Tomancok B; Nussbaumer K; Adelwöhrer C; Holl K
    Clin Neurol Neurosurg; 2004 Mar; 106(2):97-103. PubMed ID: 15003298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraventricular hemorrhage is associated with early hydrocephalus, symptomatic vasospasm, and poor outcome in aneurysmal subarachnoid hemorrhage.
    Wilson TJ; Stetler WR; Davis MC; Giles DA; Khan A; Chaudhary N; Gemmete JJ; Xi G; Thompson BG; Pandey AS
    J Neurol Surg A Cent Eur Neurosurg; 2015 Mar; 76(2):126-32. PubMed ID: 25545809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenestration of the lamina terminalis as a valuable adjunct in aneurysm surgery.
    Andaluz N; Zuccarello M
    Neurosurgery; 2004 Nov; 55(5):1050-9. PubMed ID: 15509311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing subarachnoid fibrinolytic therapy for aneurysmal subarachnoid hemorrhage.
    Macdonald RL
    World Neurosurg; 2010 Jun; 73(6):622-3. PubMed ID: 20934139
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage by intraoperative cisternal fibrinolysis using tissue-type plasminogen activator combined with continuous cisternal drainage.
    Kinouchi H; Ogasawara K; Shimizu H; Mizoi K; Yoshimoto T
    Neurol Med Chir (Tokyo); 2004 Nov; 44(11):569-75; discussion 576-7. PubMed ID: 15686175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of cerebrospinal fluid drainage in patients with aneurysmal subarachnoid hemorrhage for prevention of symptomatic vasospasm and late hydrocephalus.
    Hirashima Y; Kurimoto M; Hayashi N; Umemura K; Hori E; Origasa H; Endo S
    Neurol Med Chir (Tokyo); 2005 Apr; 45(4):177-82; discussion 182-3. PubMed ID: 15849454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.
    Findlay JM; Kassell NF; Weir BK; Haley EC; Kongable G; Germanson T; Truskowski L; Alves WM; Holness RO; Knuckey NW
    Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of combining continuous cerebrospinal drainage and intermittent intrathecal urokinase injection therapy in preventing symptomatic vasospasm following aneurysmal subarachnoid haemorrhage.
    Yamada K; Yoshimura S; Enomoto Y; Yamakawa H; Iwama T
    Br J Neurosurg; 2008 Oct; 22(5):649-53. PubMed ID: 18686067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute hydrocephalus and chronic hydrocephalus with the need of postoperative shunting after aneurysmal subarachnoid hemorrhage.
    Lin CL; Kwan AL; Howng SL
    Kaohsiung J Med Sci; 1999 Mar; 15(3):137-45. PubMed ID: 10224837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator.
    Mizoi K; Yoshimoto T; Takahashi A; Fujiwara S; Koshu K; Sugawara T
    J Neurosurg; 1993 Mar; 78(3):430-7. PubMed ID: 8433145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraventricular tissue plasminogen activator in subarachnoid hemorrhage patients: a prospective, randomized, placebo-controlled pilot trial.
    Kramer AH; Roberts DJ; Holodinsky J; Todd S; Hill MD; Zygun DA; Faris P; Wong JH
    Neurocrit Care; 2014 Oct; 21(2):275-84. PubMed ID: 24627207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between shunt-dependent hydrocephalus after subarachnoid haemorrhage and duration of cerebrospinal fluid drainage.
    Ohwaki K; Yano E; Nakagomi T; Tamura A
    Br J Neurosurg; 2004 Apr; 18(2):130-4. PubMed ID: 15176553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.